Changeflow GovPing Healthcare & Life Sciences Voice-Based Blood Glucose Prediction via Machin...
Routine Notice Added Final

Voice-Based Blood Glucose Prediction via Machine Learning

Favicon for changeflow.com USPTO Patent Applications - Health Informatics (G16H)
Published
Detected
Email

Summary

KVI BRAVE FUND I INC. filed patent application US20260112492A1 on April 23, 2026 for systems and methods predicting blood glucose levels using voice samples via machine learning. Inventors Yan FOSSAT and Jouhyun JEONG developed methods receiving voice samples at multiple time points paired with corresponding blood glucose measurements, sorting samples into glucose level categories, extracting voice features, and generating a blood glucose prediction model based on selected features. The application was filed December 2, 2025 under application number 19405524.

“Provided are methods and systems for generating a model for determining blood glucose levels using voice samples.”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors USPTO Patent Applications - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 146 changes logged to date.

What changed

KVI BRAVE FUND I INC. filed a patent application (US20260112492A1) with the USPTO for systems and methods of predicting blood glucose levels using voice analysis and machine learning. The application covers receiving voice samples from subjects at multiple time points along with temporally associated blood glucose measurements, sorting samples into glucose level categories, extracting voice feature values, selecting a subset of features, and generating a prediction model. CPC classifications include G16H 50/20, A61B 5/14532, and G10L 25/66, indicating health informatics and voice processing technologies.

Affected parties include companies developing non-invasive blood glucose monitoring technologies, health informatics platforms, and voice-based diagnostic tools. The patent application, if granted, would give KVI BRAVE FUND I INC. exclusive rights to this voice-based glucose prediction methodology, potentially affecting competitors in the continuous glucose monitoring and digital health sectors.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

SYSTEMS AND METHODS FOR GENERATING MODELS FOR DETERMINING BLOOD GLUCOSE LEVELS USING VOICE

Application US20260112492A1 Kind: A1 Apr 23, 2026

Assignee

KVI BRAVE FUND I INC.

Inventors

Yan FOSSAT, Jouhyun JEONG

Abstract

Provided are methods and systems for generating a model for determining blood glucose levels using voice samples. This includes receiving, at a processor: a plurality of voice samples from at least one subject at a plurality of time points; and a plurality of blood glucose levels, wherein each blood glucose level in the plurality of blood glucose levels is temporally associated with a voice sample in the plurality of voice samples; sorting, at the processor, the plurality of voice samples into two or more blood glucose level categories based on the blood glucose levels; extracting, at the processor, voice feature values for a set of voice features from each of the plurality of voice samples; selecting, at the processor, a subset of voice features from the set of voice features; and generating at the processor, the blood glucose level prediction model based on the subset of voice features.

CPC Classifications

G16H 50/20 A61B 5/14532 A61B 5/4803 G10L 25/03 G10L 25/66 G16H 40/67

Filing Date

2025-12-02

Application No.

19405524

View original document →

Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Technology companies Healthcare providers
Industry sector
5112 Software & Technology 3345 Medical Device Manufacturing
Activity scope
Patent application Health informatics Medical device R&D
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!